Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis (Abstract)

Initial Findings of an Open-Label Trial of Low-Dose Naltrexone for Symptomatic Mesenteric Panniculitis J Clin Gastroenterol October 2015 https://www.academia.edu/28700218/Initial_Findings_of_an_Open_Label_Trial_of_Low_Dose_Naltrexone_for_Symptomatic_Mesenteric_Panniculitis Three adults with symptomatic mesenteric panniculitis were treated with 4.5mg of LDN nightly for 12 weeks. Clinical response was defined as diminution of symptoms at 4 and 8 weeks. A biochemical response was reduction in the […]